These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2191814)

  • 41. Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood.
    Abildgaard U; Lindahl AK; Sandset PM
    Haemostasis; 1991; 21(4):254-7. PubMed ID: 1794751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples.
    Novotny WF; Brown SG; Miletich JP; Rader DJ; Broze GJ
    Blood; 1991 Jul; 78(2):387-93. PubMed ID: 2070076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of tissue factor and tissue factor pathway inhibitor in health and disease states.
    DelGiudice LA; White GA
    J Vet Emerg Crit Care (San Antonio); 2009 Feb; 19(1):23-9. PubMed ID: 19691583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Vascular function tests for diagnosis of blood coagulation disorders].
    Maruyama I
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):839-43. PubMed ID: 1919197
    [No Abstract]   [Full Text] [Related]  

  • 45. The coagulation cascade in sepsis.
    Wang L; Bastarache JA; Ware LB
    Curr Pharm Des; 2008; 14(19):1860-9. PubMed ID: 18691097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood coagulation, fibrinolysis and platelet function in women aged 38, 46, 50, 54 and 60. The study of women in Gothenburg 1968-1969.
    Korsan-Bengtsen K; Bengtsson C; Tibblin E
    Acta Med Scand; 1973 Jun; 193(6):543-6. PubMed ID: 4721963
    [No Abstract]   [Full Text] [Related]  

  • 47. Lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Curr Stud Hematol Blood Transfus; 1991; (58):22-5. PubMed ID: 1954769
    [No Abstract]   [Full Text] [Related]  

  • 48. Blood coagulation factors in the elderly.
    Hager K; Setzer J; Vogl T; Voit J; Platt D
    Arch Gerontol Geriatr; 1989; 9(3):277-82. PubMed ID: 2640086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.
    Bajaj MS; Kuppuswamy MN; Saito H; Spitzer SG; Bajaj SP
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8869-73. PubMed ID: 2247459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue factor pathway inhibitor revisited.
    Hjort PF; Sandset PM; Abildgaard U; Rao LV; Mast A; Ott I; Bajaj SP
    J Thromb Haemost; 2004 Dec; 2(12):2241-9. PubMed ID: 15613032
    [No Abstract]   [Full Text] [Related]  

  • 51. Screening for inherited thrombotic disorders.
    Conard J; Horellou MH; Samama MM
    Ric Clin Lab; 1989; 19(4):391-402. PubMed ID: 2534441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Release of extrinsic pathway inhibitor after heparin injection: increased response in cancer patients.
    Lindahl AK; Abildgaard U; Stokke G
    Thromb Res; 1990 Aug; 59(3):651-6. PubMed ID: 2237832
    [No Abstract]   [Full Text] [Related]  

  • 53. The role of tissue factor pathway inhibitor in a revised coagulation cascade.
    Broze GJ
    Semin Hematol; 1992 Jul; 29(3):159-69. PubMed ID: 1641662
    [No Abstract]   [Full Text] [Related]  

  • 54. Does plasmin have anticoagulant activity?
    Hoover-Plow J
    Vasc Health Risk Manag; 2010 Apr; 6():199-205. PubMed ID: 20407627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipid-related clotting reactions of clinical significance.
    Bowie EJ
    Arch Pathol Lab Med; 1992 Dec; 116(12):1345-9. PubMed ID: 1456882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coagulation and fibrinolysis in human acute lung injury--new therapeutic targets?
    Ware LB; Bastarache JA; Wang L
    Keio J Med; 2005 Sep; 54(3):142-9. PubMed ID: 16237276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation.
    Lindahl AK; Abildgaard U; Larsen ML; Aamodt LM; Nordfang O; Beck TC
    Thromb Res Suppl; 1991; 14():39-48. PubMed ID: 1658969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor.
    Novotny WF; Palmier M; Wun TC; Broze GJ; Miletich JP
    Blood; 1991 Jul; 78(2):394-400. PubMed ID: 2070077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Tissue factor and inhibitor of the blood coagulation pathway in nephrotic syndrome].
    Małyszko JS; Małyszko J; Myśliwiec M
    Pol Arch Med Wewn; 1999 Apr; 101(4):301-5. PubMed ID: 10740407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Basic knowledge on coagulation and fibrinolysis to understand thrombus-formation machinery].
    Urano T; Suzuki Y
    Nihon Rinsho; 2014 Jul; 72(7):1198-205. PubMed ID: 25163308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.